Biomet reveals SEC subpoena over alleged 'improprieties' in Brazil, Mexico

More than 2 years after inking a $22 million deal to settle charges that it violated the Foreign Corrupt Practices Act, Biomet says the SEC issued a subpoena over alleged "improprieties" in Brazil and Mexico.

Biomet, Dept. of Justice (DOJ), Securities & Exchange Commission (SEC)

Legal News, News Well, Exports, Orthopedics

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/Vz73lt